Reducing Edema After intraCerebral Hemorrhage

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT05263167

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05263167
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05263167. Randomized; quadruple masking; primary purpose treatment. Start 2022-03-15 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Reducing Edema After intraCerebral Hemorrhage
Condition
Edema Brain
Intervention (Drug)
Sodium Aescinate
Intervention (Drug)
Placebo
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct05263167
Content hash
f25d05688ea6931a573e34d60bd89a25ec0f5f16d7a7f40e4b0534a39f6a771e